BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29885530)

  • 1. A multi-functional polymeric carrier for simultaneous positron emission tomography imaging and combination therapy.
    Sun J; Sun L; Li J; Xu J; Wan Z; Ouyang Z; Liang L; Li S; Zeng D
    Acta Biomater; 2018 Jul; 75():312-322. PubMed ID: 29885530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
    Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
    Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
    Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S
    Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
    Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
    Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
    Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
    Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
    Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
    ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
    Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
    Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents.
    Xu J; Zhao W; Sun J; Huang Y; Wang P; Venkataramanan R; Yang D; Ma X; Rana A; Li S
    J Control Release; 2018 Oct; 288():212-226. PubMed ID: 30223045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
    Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
    Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs.
    Xu J; Sun J; Wang P; Ma X; Li S
    J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
    Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
    Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
    Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
    Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
    Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
    Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
    AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer.
    Luo Z; Xu J; Sun J; Huang H; Zhang Z; Ma W; Wan Z; Liu Y; Pardeshi A; Li S
    Acta Biomater; 2020 Mar; 105():239-252. PubMed ID: 31958597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.